Breaking Cornea Innovation Patient Education Treatment Surgical innovation in dry eye disease: Salivary gland transplant Ağustos 27, 2025
Breaking Cataract Patient Education Surgery Technology Alcon presenting at APACRS 2025 Ağustos 21, 2025
Breaking Cataract Cornea Hyperopia LASIK Myopia Patient Education PRK Surgery Next-generation IOLs advance complex cataract care Ağustos 26, 2025
Breaking Cataract Patient Education Recommendation Surgery Treatment Global Spotlight: The Most Cost-Effective Countries for Cataract Surgery Eylül 10, 2025
Home Industry News ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones – Company Announcement – FT.com – Financial Times Share your love
ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones – Company Announcement – FT.com Financial Times Source: Author: | Date: 2025-09-02 12:00:00 Source: Author: | Date: 2025-09-02 12:00:00 Share your love Previous Yazı EyeCool Therapeutics names Dr Vance Thompson to Board - Medical Buyer Next Yazı ZEISS showcases expansion of ophthalmic care options creating industry-leading workflow solutions; marks new refractive and cataract milestones - The Globe and Mail Related Posts AAO 2026 Highlights Hospital Ophthalmology Coverage Gaps and Growing Reimbursement PressuresEkim 11, 2026 Inflammasome Therapeutics’ Kamuvudine K8 Reduces Geographic Atrophy Lesion Growth by 54% in Phase 2 StudyEkim 9, 2026 GenSight Biologics Publishes GS030 PIONEER Optogenetic Therapy Results in the New England Journal of MedicineEkim 8, 2026 Leave a ReplyCancel ReplyE-posta adresiniz yayınlanmayacak. Gerekli alanlar * ile işaretlenmişlerdir Name * Email * Website Add Comment * Save my name, email and website in this browser for the next time I comment.Yorum gönder
AAO 2026 Highlights Hospital Ophthalmology Coverage Gaps and Growing Reimbursement PressuresEkim 11, 2026
Inflammasome Therapeutics’ Kamuvudine K8 Reduces Geographic Atrophy Lesion Growth by 54% in Phase 2 StudyEkim 9, 2026
GenSight Biologics Publishes GS030 PIONEER Optogenetic Therapy Results in the New England Journal of MedicineEkim 8, 2026
